Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 294 participants.

Also called NCT02175225

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 294 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02175225
Other papers using this trial's data
  • Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial The Lancet. Neurology, 2019-05 DOI, PubMed 30898550, PMC6494117 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Early neurological improvement with deferoxamine after intracerebral hemorrhage: A post hoc analysis of the i-DEF trial International journal of stroke : official journal of the International Stroke Society, 2025-12 DOI, PubMed 40418029, PMC12664922 In the PMC Open Access subset under CC BY.
  • Effect of Deferoxamine on Trajectory of Recovery After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial Stroke, 2022-07 DOI, PubMed 35306827, PMC9246960 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Evolution of Perihematomal Edema Mean Hounsfield Unit and Its Association with Clinical Outcome in Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial Neurocritical care, 2025-12 DOI, PubMed 40789806, PMC12647195 In the PMC Open Access subset under CC BY.
  • Hemoglobin and Perihematomal Edema After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial Neurocritical care, 2026-02 DOI, PubMed 40399657, PMC12819462 In the PMC Open Access subset under CC BY.
  • The Prognostic Roles of Perihematomal Edema and Ventricular Size in Patients with Intracerebral Hemorrhage Neurocritical care, 2022-10 DOI, PubMed 35676589

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02175225. Randomized; quadruple masking; primary purpose treatment. Start 2014-10 (actual); primary completion 2018-02-10 (actual). Results posted on 2019-05-30.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Condition
Intracerebral Hemorrhage
Intervention (Drug)
Deferoxamine Mesylate
Intervention (Drug)
Placebo (for Deferoxamine Mesylate)
Lead sponsor
Beth Israel Deaconess Medical Center (class: other)
Collaborator
Medical University of South Carolina (class: other)
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (class: US National Institutes of Health)
Collaborator
Massachusetts General Hospital (class: other)
Collaborator
University of Massachusetts, Worcester (class: other)
Collaborator
University of Pennsylvania (class: other)
Collaborator
Johns Hopkins University (class: other)
Collaborator
Duke University (class: other)
Collaborator
University of North Carolina (class: other)
Collaborator
University of Florida (class: other)
Collaborator
Henry Ford Hospital (class: other)
Collaborator
Ohio State University (class: other)
Collaborator
St. Joseph's Hospital and Medical Center, Phoenix (class: other)
Collaborator
University of California, San Francisco (class: other)
Collaborator
Oregon Health and Science University (class: other)
Collaborator
Yale New Haven Health System Center for Healthcare Solutions (class: other)
Collaborator
University of Iowa (class: other)
Collaborator
Hartford Hospital (class: other)
Collaborator
The University of Texas Health Science Center, Houston (class: other)
Collaborator
Rhode Island Hospital (class: other)
Collaborator
Stanford University (class: other)
Collaborator
University of Washington (class: other)
Collaborator
University of Calgary (class: other)
Collaborator
Hopital de l'Enfant-Jesus (class: other)
Collaborator
University of Alberta (class: other)
Collaborator
Rush University Medical Center (class: other)
Collaborator
University Hospitals Cleveland Medical Center (class: other)
Collaborator
Columbia University (class: other)
Collaborator
Weill Medical College of Cornell University (class: other)
Collaborator
NYU Langone Health (class: other)
Collaborator
Mount Sinai Hospital, New York (class: other)
Collaborator
Loyola University (class: other)

Registry records

Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry organizations 27

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.

    Organization04drvxt59

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 17 trials in this atlas.

    Organization00hj8s172

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 19 trials in this atlas.

    Organization00py81415

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

    Organization00gt5xe03

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

    Organization0193sb042

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 26 trials in this atlas.

    Organization00za53h95

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 36 trials in this atlas.

    Organization002pd6e78

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 23 trials in this atlas.

    Organization012jban78

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

    Organization

Record details

Record id
cardio:ct-nct02175225
Content hash
58254cc52d0eeead938d7e641ee541e3e18c755421146f10d3332d0da5aaf03c